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Equine Degenerative
Joint Disease
by W. A. Horne*
Dr. R. L. Lundvallt
Introduction
We call upon the horse to perform for us
in many ways, and he does so quite willingly.
We ask him to jump and run as hard as he
can, and even still to perform gracefully in
the show ring. The tragedy that exists is that
all too often we ask too much of the horse and
a permanently disabling lameness is often the
result. Our technology has provided us with
drugs to ease his pain, and yet we are now
finding that we are probably doing him more
harm than good. The use of drugs such as
phenylbutazone and corticosteroids is now
under the scrutiny of the American public,
for it has been discovered that their use may
lead to an irreversible condition of
degenerative joint disease (DJD). It is pro-
bably the most common condition with which
a racetrack practitioner must deal. It is not
only a medical problem, but is indeed an
economic problem for the racing industry.
Anatomy and Physiology
The diarthrodial joint is composed of: (1)
a joint capsule; (2) articular cartilage; (3)
subchondral bone; (4) ligaments and tendons;
(5) nerves, lymphatics, and blood vessels; and
(6) synovial fluid. 6
The joint capsule is made up of two layers.
The outer layer consists mainly of dense
fibrous tissue. It is designed to resist stretch-
ing and thus to protect the delicate synovial
membrane which makes up the inner layer of
the joint capsule. The synovial membrane is
subdivided into an intimal and subintimal
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layer. The two predominant cell types which
are present in the intimal layer are A cells,
which are considered to be macrophages with
phagocytic properties, and B cells, which are
thought to produce hyaluronic acid. 5 The
subintimal layer consists of fibrous, alveolar
or adipose tissue which is richly supplied with
blood vessels (especially veins) and lym-
phatics. The synovial membrane is well in-
nervated for detecting pain and propriocep-
tion, and has good regenerative capacity.
This is important with respect to DJD. In
many areas the synovial membrane is folded
into primary and secondary villi.
The articular cartilage is hyaline in nature
and is composed of a mucopolysaccharide
matrix, collagen fibers, and chondrocytes. 5 It
lacks blood vessels, lymphatics, and nerves.
Nutrition of articular cartilage is accomp-
lished by diffusion of nutrients from synovial
fluid and from the capillary beds of the sub-
chondral bone below. It is arranged in three
layers; (1) a thin calcified basal layer which is
adhered to subchondral bone; (2) a thick in-
termediate layer which contains a great
amount of water, accounting for the shock
absorbing capabilities of articular cartilage,
and (3) a thin tangential layer of collagen
fibers. 6 The elasticity of articular cartilage is
related to the fact that collagen fibers are
parallel to the surface in the more superficial
layers and perpendicular to the surface in the
deeper layers of the cartilage. 5 Along with
elasticity and shock absorbing functions, it
provides a smooth gliding surface for joint
motion. Of most importance with respect to
degenerative joint disease is that cartilage has
very poor regenerative characteristics.
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Synovial fluid is a protein-containing dia-
lysate of blood plasma. It is normally
transparent and pale yellow. It contains
mucin, which is thought to be a hyaluronic
acid protein complex. Hyaluronic acid con-
tent, degree of polymerization, and viscosity
of the synovial fluid varies with range, speed,
and kind of motion of the joint. Viscosity is
highest during slow rate of motion and will
decrease as the rate of motion increases, thus
providing less resistance. 6 Synovial fluid is
said to have four important properties; (1)
constant load bearing; (2) lubrication or wet-
ting of surfaces; (3) good heat conductivity;
and (4) elasticity and the ability to become
semisolid instantly on impact, which prevents
squeezing out from the articular surfaces. l
Alsq' of importance is the hyaluronic acid-
proteoglycan matrix which exists on the sur-
face of articular cartilage and serves as a form
of boundary lubrication.
Pathology
There are a number of terms for a condi-
tion that is actually a syndrome. Arthritis is
probably the most common term, but
degenerative joint disease is probably the
most correct. Degenerative joint disease is
characterized by degeneration of cartilage
and hypertrophy of bone. l Soft tissues,
however, are markedly affected. The synovial
membrane becomes greatly thickened due to
congestion and edema. Surrounding soft
tissues are destined to become devitalized due
to loss of blood supply, and eventually fibrosis
and calcification of these tissues occurs.
Characteristically, the synovial membrane
responds by proliferating and invading the in-
terior of the joint. This inflammatory tissue
(pannus) grows from the synovium inward
along the surface of the articular cartilage to
which it is usually tightly adhered.6 The result
is an interference with the normal flow of
synovial fluid through the pores of the ar-
ticular cartilage, which results then in
decreased nutrient diffusion. The cartilage
becomes thin, weak and inelastic. The in-
vading inflammatory tissues are then con-
verted to tough fibrous tissue, which eventual-
ly being adhered to both opposing joint sur-
faces, greatly inhibits motion of the joint.
This fibrous tissue may then become calcified·
resulting in firm bony union, and obliteration
of the joint space. Radiographically, degener-
ative joint disease is characterized by uneven
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joint spaces, variable amounts of lipping, ~nd
hypertrophic new bone growth around the
joint. Sclerosis of new bone may be evident.
Then, as the disease progresses in long stan-
ding cases, ankylosis occurs. 6 Changes this ad-
vanced are irreversible.
The most significant factor in the initia-
tion of dege..nerative joint disease, especially in
the young Thoroughbred, is trauma. The
joints that are most often involved are the car-
pus and the fetlock. There are many predis-
posing factors to trauma, including con-
formation, nutrition, and condition; but most
importantly, use. 6 Degenerative joint disease
in the case of the horse is a wear and tear
phenomenon. The average Thoroughbred is
probably the most underconditioned athlete
in America. After a brief morning workout,
the racehorse spends the rest of his day stand-
ing in the stall. Not only does he often race
unprepared, which often leads to injury, but
quite often he races in spite of injury. As men-
tioned, much of a racetrack veterinary prac-
tice is time spent relieving joint pain with
drugs such as phenylbutazone and cor-
ticosteroids. It would not be far from the
truth to say that, in fact, the widespread in-
cidence of degenerative joint disease is due to
the use of these drugs.
Often DJD begins with only mild trauma,
damage occurring only to the joint capsule or
periarticular ligaments. Adams refers to this
condition as serous arthritis. 1 Clinical signs
include joint swelling, heat, and pain
evidenced by lameness. Inflammation of the
synovial membrane is very painful. The most
important aspect of this condition is that
damage to the synovial membrane results in
alteration of synovial fluid and changes in
intra-articular metabolism. The viscosity of
the synovial fluid is lowered due to decreased
hyaluronic acid production by the inflammed
synovial membrane, as well as increased
hyaluronic acid destruction due to leukocytic
enzymes. This is probably the most important
aspect of DJD. Lubrication quality is re-
duced, and friction between articular surfaces
increases substantially. Continued workouts
eventually lead to cartilage damage. In the
case of serous arthritis, fibrinogen, which is
normally absent from synovial fluid, enters
the joint resulting in the ability of the fluid to
clot, which is a diagnostic characteristic. The
number of leukocytes increases, producing a
turbid color. The increased effusion results
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from an increase in the osmotic pressure and
also from a decrease in drainage from the
joint as a result of the impaired synovial mem-
brane. 6 Radiographically, the bony structures
of the joint appear normal. However, if the
inflammation of the joint persists, erosion of
the joint cartilage and osteoarthritis may
result. Serous arthritis is a reversible condi-
tion if treated properly. All too often it is not.
The use of corticosteroids to mask the pain of
serous arthritis will, and, often does, increase
the possibility of development of degenerative
joint disease.
Severe trauma may, of course, directly
damage articular cartilage and/or subchon-
dral bone leading to a more destructive and
irreversible degenerative disease. Repair of
cartilage depends to a great extent on the site
of trauma. If it is central, repair is slow and
often incomplete, resulting in an irregular
joint surface. 6 Loss of elasticity of cartilage is
thought to be the first physiological change
leading degenerative joint disease. The loss of
chondroitin sulfate and collagen is associated
with loss of elasticity and can be attributed to
interference with nutrition of the cartilage. 5
Enzymes from leukocytes and plasminogen
are also responsible for articular damage. As
cartilage damage continues, the subchondral
bone is eventually exposed. Continued in-
flammation and wear leads to sclerosis of the
bone followed by eburnation. As the central
cartilage is lost, changes take place at the
periphery in the form of osteophytes or spurs
and lipping of joint margins. The chronically
inflammed synovial membrane becomes
hypertrophic and villi enlarge.
Treatment
There is really no satisfactory treatment
for the pathological changes which have oc-
curred in a long standing case of degenerative
joint disease. However, proper management
of the acute phase of-joint injury as in the case
of serous arthritis, can prevent further
deterioration of a joint. My personal observa-
tion is that many trainers and veterinarians
are negligent in this area. It is a difficult
situation in that decisions in many cases are
based on economics rather than what is best
for the horse. Often it is more economical to
offer temporary relief and to drop the horse in
class, hoping to sell, rather than losing time
and money with a proper course of therapy.
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Therapy is based upon the pathological
stages of trauma. Initially, there is devitaliza-
tion of tissues, hyperemia and hemmorhages,
(swelling and edema. This stage is followed by
clotting and organization of the area, fibrosis
and decreased blood supply. Finally, adhe-
sions and calcification of soft tissues occurs,
caused by either the metamorphosis of fibro-
blasts into osteoblasts or the increased pH due
to poor circulation and devitalized tissues. 6
Initially then, therapy is aimed at reduc-
ing hemmorhage and edema, and to relieve
pain. Cold in combination with compression
and rest will achieve vasoconstriction and thus
reduce swelling. It also provides some relief of
pain. Cold is best applied for 20-40 minute
applications, and at least one hour should
elapse before it is reapplied. If cold is applied
too long, there may be a reflex vasodilation. l
At this time the joint can be injected with a
corticosteroid to relieve inflammation, but
absolute rest must follow. 5 It may be
necessary to immobilize the joint with a cast
for two to six weeks depending on the severity
of the injury. Once the acute inflammatory
phase is under control, heat, linaments, and
exercise should be used to promote motion,
the aim being to reduce or prevent adhesions.
Heat causes vasodilation and increases the
number of phagocytes in the area, as well as
increases oxygen supply to the part. 1 In some
chronic cases, it may be desireable to blister,
fire, or apply radiation therapy. According to
Adams, firing and radiation therapy promote
an acute inflammation of the joint; when the
acute inflammation subsides, the arthritis
may heal and a sound joint result. 1 The most
important part of therapy is the adequate rest
prescribed. Anywhere from one to six months
is necessary. Working the horse too soon may
cause re-injury or may lead to osteoarthritis
and ulceration of joint cartilage. The pro-
gnosis is usually favorable if bony changes
have not occurred.
Once bony changes have occurred the
prognosis becomes guarded. If new bone
growth occurs on the articular surfaces,
mechanical interference factors result in
chronic lameness. The only conservative
alternatives are firing, blistering, or radiation
therapy. Firing has been acclaimed for its
ability to remove osseous growth, however the
inflamation it produces rarely causes any
demineralization. l Soft tissue swelling is
usually all that is reduced. The use of
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counterirritation is indeed controversial.
Mechanisms of action are not well under-
stood. Some say it is barbaric, others swear by
it. More often than not, the results of counter- ~
irritation are disappointing at best.
Surgery is always a consideration when ex-
tensive bony changes have occurred. Fresh
chip fractures often heal if they have good
blood supply and if there is minimum separa-
tion of the articular cartilage. 6 Chip fractures
are often involved in the induction of
degenerative joint disease, simply by
mechanical disruption of joint surfaces with
continued work. If small chips are going to be
left alone, the horse should have complete rest
and the healing process should be monitored
radiographically at four to six week intervals ..
Separation of the fragment with possible
disruption of blood supply is a good indica-
tion for removal or stabilization of the frac-
ture fragment. 6 Of primary concern is the
fact that one cannot see cartilage damage
radiographically. Slight bone abnormalities
may be indicative of more extensive cartilage
damage. As a rule, osteophytes or fracture
fragments which are removed will be much
larger than the radiographs may indicate.
The important thing to remember is that in
addition to removal of a spur or fracture frag-
ment, care must be taken to remove all the
reactive underlying· subchondral bone. This
bone is usually found to be soft which is in-
dicative of degenerative changes. If left un-
disturbed it will proliferate, therefore one
should currette until solid, normal bone is
reached. If properly done, follow up
radiographs will show minimal bony pro-
liferation. Also of surgical consideration is the
removal of hypertrophic synovial villi which
have extended into the joint. As stated, the
synovial membrane is well supplied with
many nerves and entrapment between ar-
ticular surfaces results in pain. In any case,
post-surgical aftercare should consist of at
least four to eight months of rest to allow for
proper healing.
The dissatisfaction with conservative
methods of therapy has lead to the wide-
spread use of intra-articular corticosteroids.
Intra-articular injection of corticosteroids will
allow a horse to use a joint which has exten-
sive pathologic changes. The exact mecha-
nism of anti-inflammatory action is unknown,
however, some feel that they act as buffers be-
tween irritants and susceptible cells. 1
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Somehow it alters damaged cells so they are
less effective in producing substances respon-
sible for the initiation of inflammation. Cor-
ticoids inhibit fibrocyte proliferation and
healing. They are responsible for stabilizing
intimal cells, protecting synovial vessels, and
improving circulation by reducing edema. 5
Thus, the synovium in an injured joint is
returned temporarily to a more normal state,
enabling it to produce more synovial fluid
which improves lubrication of the synovium.
The immediate effects on synovial fluid are
(1) increased viscosity (2) increased
polymerization of hyaluronic acid (3) reduced
synovial volume and (4) a reduction in the
leukocyte count. 5 These effects are responsi-
ble for the clinical improvement seen as
reduced joint stiffness and pain, which
enables the horses to use the joint more freely.
There is widespread misuse of cor-
ticosteroids at the present. A joint should not
be injected with a corticoid without prior
radiologic examination. If a fracture is pres-
ent, the joint should not be injected if any
long-term working future is expected for the
horse. The ill-advised injection of a cor-
ticosteroid during the time of degenerative ar-
thritis or repairable fractures frequently
causes a more rapid destruction of the joint
with the production of extensive degenerative
lesions that cannot be corrected by surgery.
This causes many hopeless cases to be
presented for surgery when the corticosteroids
are no longer effective, whereas if they had
been operated on early, a successful result
could have been anticipated. 5 Although the
immediate effect of corticosteroids are an in-
creased production of hyaluronic acid due to
decreased synovial membrane inflammation
and stabilization of chondroblasts, the long
term effects with continued use are a reduc-
tion in hyaluronic acid synthesis and a
catabolism of chondroblasts.4 Damage to
chondroblasts results in cartilage thinning
and a loss of cartilage elasticity. If a horse is
allowed to continue working, extensive joint
damage inevitably results. It must be stressed
that intrarticular corticosteroids can be
beneficial if used only for a short time and if
followed by adequate rest, for they merely
decrease inflammation while healing occurs.
Too often, the corticoids are used to mask
symptoms, and the horse is allowed to further
damage the joint. 1
There is a need, then, for a drug with the
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pOSItIve action of corticosteroids which does
not have it deleterious side effects. Rydell first
reported on the prolongation of the anti-
inflammatory effects of corticosteroids when
they were injected along with hyaluronic
acid. 7 Current research is investigating the
use of intra-articular hyaluronic acid alone.
Hyaluronic acid is a non-sulfated polysac-
charide from which synovial fluid derives it
characteristic high viscosity.3 It exists not only
in the synovial fluid, but also is incorporated
along with proteoglycans in a 1-10 micron
thick protective layer which covers the ar-
ticular surface. 5 Thus it forms a type of elastic
cushion, serving to protect articular cartilage
cells. Large concentrations of high molecular
weight hyaluronic acid are required. In
degenerative joint disease there is often a
decrease in hyaluronic acid production as well
as a breakdown of existing molecules. The
protective function of hyaluronic acid is
therefore lost. With continued use of the af-
fected joint cartilage erosion results. Current
research, however, is revealing that intra-ar-
ticular injection of hyaluronic acid may serve
as an adequate replacement. 2
There are many sources of hyaluronic
acid, but the molecule may vary with respect
to size and its ability to form complexes with
proteoglycans. Currently, hyaluronic acid
from human umbilical cord seems to meet the
requirements for replacement most satisfac-
torally. Hyaluronic acid derived from rooster
combs has also served as a good source. That
which has been derived from bovine vitreous
has been shown to cause adverse reactions. 8
In a study by Asheim and Lindblad, forty-
five race horses with arthritis of non-infec-
tious type (a total of 54 joints) were treated
with hyaluronic acid intra-articularly. 2 These
joints had previously undergone therapy with
other methods (firing, blistering, steroids,
etc.) without satisfactory results. In most cases
only one 40 mg. injection was all that was re-
quired for satisfactory results. Evaluation of
the joints was made on the basis of per-
formance, and of the forty-five cases, thirty-
eight were free from lameness, and thirty-two
of them returned to the racetrack and went
on to win races. They were observed over a
period of one year. Only those cases with pro-
nounced osteophyte outgrowth required re-
injection. There were no side effects observed.
In fact there were two cases in which horses
with bone fractures extending into the joint
18
showed marked improvement following intra-
articular injection of hyaluronic acid. They
concluded that hyaluronic acid acts directly
on the surfaces within the joint, not only
through its viscoelastic properties but also by
a normalization of the hyaluronic acid syn-
thesis. 2 The persisting effects of injection are
explained by improving the character of the
synovial membrane and fluid.
In order to study the effects of intra-artic-
ular hyaluronic acid more quantitatively a
force plate study was designed by Auer et. al.
on horses with both experimentally induced
and naturally occurring osteoarthritis. 3 In
both groups they demonstrated marked im-
provement of weight bearing capacity of the
damaged joint as soon as two weeks following
injection. In fact, three of the ten horses in
the naturally occurring osteoarthritic group
were racing again within two weeks.
The exact mechanism of functional im-
provement of a joint following intra-articular
injection of hyaluronic acid is not well known.
As mentioned, hyaluronic acid is known to
exist freely within the synovial fluid and is also
incorporated into the surface of articular car-
tilage in a proteoglycan matrix. Histological
examination of an arthritic joint reveals a
general loss of both proteoglycan and car-
tilage substance. Recall, also that there is
decreased production of hyaluronic acid in
arthritic joints. Aggregation of proteoglycans
on the surface of articular cartilage is greatly
reduced and these subunits are found floating
freely within the joint fluid. It is believed that
they are involved in the initiation of an in-
flammatory response. In vitro studies of ar-
thritic human cartilage have shown that in-
cubation of proteoglycan subunits with
hyaluronic acid results in marked aggregation
of these substances. It is therefore believed
that hyaluronic acid serves to bind pro-
teoglycans, and thus is of primary importance
in the construction of the matrix which exists
of the articular surface. Intra-articular injec-
tion of hyaluronic acid therefore improves the
boundary lubrication of the joint surface by
reconstructing the proteoglycan matrix, and
reduces inflammation by removing pro-
teoglycan subunits from joint fluid. 3
It appears then that intra-articular injec-
tion of hyaluronic acid may be a successful
means of dealing with degenerative joint
disease. Its use is without the deleterious side
defects of multiple corticosteroid injections.
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Corticosteroids have an anti-inflammatory ef-
fect on diseased and damaged joints, masking
clinical signs, rendering the joint pain free
and permitting the horse to return to work. 6
The natural healing tendencies of the ar-
ticular cartilage or joint capsule is therefore
eliminated. Hyaluronic acid acts to lubricate
synovial tissues and to improve. the quality of
the proteoglycan matrix of articular car-.
tilage. 3 Natural healing tendencies are en-
couraged rather than depressed.
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